BTG3 and uveitis: This may be due to our study's preselection on ANA-positive patients, as well as to the generally lower prevalence of antinuclear antibodies in healthy children (29, 43) and/or in JIA patients without uveitis, as compared to JIA patients with uveitis (44, 45) or CTD (46–48).